Aspartic Acid

Aspartic Acid

SCHEMBL29564328

N[C@@H](CC(=O)O)C(=O)O.O=C1C=CC(=O)N1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SSTR1SSTR2SSTR3SSTR5

The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
CCR6 P51684 1/20 0.42
GRIK1 P39086 10/20 0.39
GRIK2 Q13002 5/20 0.39
GRM1 Q13255 2/20 0.39
GRM2 Q14416 2/20 0.39
GRIA2 P42262 5/20 0.38
GRIA4 P48058 5/20 0.38
GRIK3 Q13003 4/20 0.38
GRIK5 Q16478 4/20 0.38
GRIA1 P42261 4/20 0.38
SLC7A5 Q01650 2/20 0.38
GRIA3 P42263 2/20 0.38
GRM8 O00222 1/20 0.38
GRM6 O15303 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GSR P00390 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aspartic Acid SCHEMBL29024585 1.00 GSK3A (0.42) GSK3AGSK3BCCR6GRIK1GRIK2
SCHEMBL29024590 0.87 GSK3A (0.41) GSK3AGSK3BCCR6
Cysteine SCHEMBL16208953 0.81 PTGS1 (0.61) GSK3AGSK3BCCR6GRIK1GRIA2
Cysteine SCHEMBL987552 0.81 PTGS1 (0.61) GSK3AGSK3BCCR6GRIK1GRIA2
Cysteine SCHEMBL27864571 0.81 PTGS1 (0.61) GSK3AGSK3BCCR6GRIK1GRIA2
Aspartic Acid SCHEMBL11065189 0.78 GRIK1 (0.56) GRIK1GRIK2GRM1GRM2GRIA2
Aspartic Acid SCHEMBL3231 0.78
Aspartic Acid SCHEMBL1526976 0.78 GRIK1 (0.56) GRIK1GRIK2GRM1GRM2GRIA2
Aspartic Acid SCHEMBL996424 0.78 GRIK1 (0.56) GRIK1GRIK2GRM1GRM2GRIA2
Aspartic Acid SCHEMBL3230 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225768-A1 MODIFICATION OF A NANOPORE FORMING PROTEIN OLIGOMER Oxford Nanopore Technologies PLC (GB) 2023-08-16 EP disclosed
WO-2022074397-A1 MODIFICATION OF A NANOPORE FORMING PROTEIN OLIGOMER OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) 2022-04-14 WO disclosed